Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04092075 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the ToothWave -12 Weeks Calculus Study
A NA study, sponsored by Home Skinovations.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT04092075: Completed NA study, sponsored by Home Skinovations.
NCT04092075 is a NA study that has completed, run by Home Skinovations. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04092075, a NA study, has completed, sponsored by Home Skinovations.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.
Primary Outcome
A reduction of calculus deposits as compared to control, as evaluated by Volpe-Manhold Index.
Interventions
- DEVICE Control placebo with no RF
- DEVICE RF-utilizing powered toothbrush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2019-08-07 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
What the finished NCT04092075 record still lists
NCT04092075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Control placebo with no RF is the first listed.
NCT04092075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04092075 about?
NCT04092075 is a clinical study titled "Safety and Efficacy of the ToothWave -12 Weeks Calculus Study". The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.
What is the current status of trial NCT04092075?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2019-08-07. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT04092075?
The interventions under investigation include: Control placebo with no RF (DEVICE), RF-utilizing powered toothbrush (DEVICE).
Who is sponsoring clinical trial NCT04092075?
This trial is sponsored by Home Skinovations, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04092075's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI